Women with Luminal B-like (HER2−), HER2+, or TNBC tumours were younger than women with Luminal A-like tumours (mean age 59 years, 57 years, and 57 years vs. 62 years, respectively). This evidence concerns the gene ERBB2 and neoplasm.